Brought to you by
ECR 2015 / C-0664
Value of bimodal 18F-Choline-PET/MRI and trimodal 18F-Choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy
This poster is published under an open license. Please read the disclaimer for further details.
Congress: ECR 2015
Poster No.: C-0664
Type: Educational Exhibit
Keywords: Prostheses, Technical aspects, Diagnostic procedure, Computer Applications-Virtual imaging, Ultrasound, PET-CT, MR, Pelvis, Oncology, Genital / Reproductive system male
Authors: L. Cevasco, F. Paparo, L. Bacigalupo, R. Piccazzo, C. Puppo, E. Aleo, G. A. Rollandi; Genoa/IT


1. Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, Van der Kwast T, Wiegel T, Zattoni F, Heidenreich A (2011) EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59:572-83. doi:10.1016/j.eururo.2011.01.025
2. De Visschere PJ, Vargas HA, Ost P, De Meerleer GO, Villeirs GM (2013) Imaging treated prostate cancer. Abdom Imaging 38:1431-46. doi: 10.1007/s00261-013-9998-3

3. Kitajima K, Murphy RC, Nathan MA (2013) Choline PET/CT for imaging prostate cancer: an update. Ann Nucl Med 27:581-91. doi: 10.1007/s12149-013-0731-7
4. Martino P, Scattoni V, Galosi AB, Consonni P, Trombetta C, Palazzo S, Maccagnano C, Liguori G, Valentino M, Battaglia M, Barozzi L (2011) Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy,
HIFU). World J Urol 29:595-605. doi: 10.1007/s00345-011-0687-y
5. Beresford MJ, Gillatt D, Benson RJ, Ajithkumar T (2010) A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence. Clin Oncol (R Coll Radiol) 22:46-55. doi: 10.1016/j.clon.2009.10.015
6. Kitajima K, Murphy RC, Nathan MA, Froemming AT, Hagen CE, Takahashi N, Kawashima A (2014) Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. J Nucl Med 55:223-32. doi: 10.2967/jnumed.113.123018
7. Lecouvet FE, El Mouedden J, Collette L, Coche E, Danse E, Jamar F, Machiels JP, Vande Berg B, Omoumi P, Tombal B (2012) Can whole-body magnetic resonance imaging with diffusionweighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 62:68-75. doi:10.1016/j.eururo.2012.02.020
8. Venkitaraman R, Cook GJ, Dearnaley DP, Parker CC, Khoo V, Eeles R, Huddart RA, Horwich A, Sohaib SA (2009) Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer. J Med Imaging Radiat Oncol 53:241-7. doi: 10.1111/j.1754-9485.2009.02070.x
9. Piccardo A, Paparo F, Picazzo R, Naseri M, Ricci P, Marziano A, Bacigalupo L, Biscaldi E, Rollandi GA, Grillo-Ruggieri F, Farsad M (2014) Value of fused 18F-Choline-PET/MRI to evaluate prostate cancer relapse in patients showing biochemical recurrence after EBRT: preliminary results. Biomed Res Int 2014:103718. doi: 10.1155/2014/103718
10. Fortuin A, Rooij Md, Zamecnik P, Haberkorn U, Barentsz J (2013) Molecular and functional imaging for detection of lymph node metastases in prostate cancer. Int J Mol Sci 14:13842-75. doi: 10.3390/ijms140713842
11. Paparo F, Piccazzo R, Cevasco L, Piccardo A, Pinna F, Belli F, Bacigalupo L, Biscaldi E, De Caro G, Rollandi GA (2014) Advantages of percutaneous abdominal biopsy under PETCT/ultrasound fusion imaging guidance: a pictorial essay. Abdom Imaging. [Epub ahead of print]
12. Park H, Wood D, Hussain H, Meyer CR, Shah RB, Johnson TD, Chenevert T, Piert M (2012) Introducing parametric fusion PET/MRI of primary prostate cancer. J Nucl Med 53:546-51. doi: 10.2967/jnumed.111.091421

13. Ewertsen C, Saftoiu A, Gruionu LG, Karstrup S, Nielsen M (2013) Real-time image fusion involving diagnostic ultrasound. AJR Am J Roentgenol 200:249-55. doi: 10.2214/AJR.12.8904
14. Wetter A, Lipponer C, Nensa F, Beiderwellen K, Olbricht T, Rübben H, Bockisch A, Schlosser T, Heusner TA, Lauenstein TC (2013) Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate: initial results. Invest Radiol 48:256-62. doi: 10.1097/RLI.0b013e318282c654
15. Wetter A, Lipponer C, Nensa F, Heusch P, Rübben H, Altenbernd JC, Schlosser T, Bockisch A, Pöppel T, Lauenstein T, Nagarajah J (2014) Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CT. Eur J Nucl Med Mol Imaging 41:79-88. doi: 10.1007/s00259-013-2560-2
16. Pichler BJ, Wehrl HF, Kolb A, Judenhofer MS (2008) Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? Semin Nucl Med 38:199-208. doi: 10.1053/j.semnuclmed.2008.02.001
17. Wetter A, Lipponer C, Nensa F, Heusch P, Rübben H, Schlosser TW, Pöppel TD, Lauenstein TC, Nagarajah J (2014) Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis. Ann Nucl Med 28:405-
10. doi: 10.1007/s12149-014-0825-x
18. Abi-Jaoudeh N, Kruecker J, Kadoury S, Kobeiter H, Venkatesan AM, Levy E, Wood BJ (2012) Multimodality image fusion-guided procedures: technique, accuracy, and applications. Cardiovasc Intervent Radiol 35:986-98
19. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC (1998) Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22:139-52
20. Moul JW (2000) Prostate specific antigen only progression of prostate cancer. J Urol 163:1632-42
21. King CR, Kapp DS (2008) Radiotherapy after prostatectomy: is the evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 71:346-50. doi: 10.1016/j.ijrobp.2007.10.008
22. Rouvière O (2012) Imaging techniques for local recurrence of prostate cancer: for whom, why and how? Diagn Interv Imaging 93:279-90. doi: 10.1016/j.diii.2012.01.012
23. Cirillo S, Petracchini M, Scotti L, Gallo T, Macera A, Bona MC, Ortega C, Gabriele P, Regge D (2009) Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 19:761-9. doi: 10.1007/s00330-008-1174-8
24. Sciarra A, Panebianco V, Salciccia S, Osimani M, Lisi D, Ciccariello M, Passariello R, Di Silverio F, Gentile V (2008) Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 54:589-600. doi: 10.1016/j.eururo.2007.12.034
25. Casciani E, Polettini E, Carmenini E, Floriani I, Masselli G, Bertini L, Gualdi GF (2008) Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. AJR Am J Roentgenol 190:1187-92. doi: 10.2214/AJR.07.3032
26. Vees H, Buchegger F, Albrecht S, Khan H, Husarik D, Zaidi H, Soloviev D, Hany TF, Miralbell R (2007) 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy. BJU Int 99:1415-20
27. Giovacchini G, Picchio M, Scattoni V, Garcia Parra R, Briganti A, Gianolli L, Montorsi F, Messa C (2010) PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging 37:1106-16. doi: 10.1007/s00259-010-1403-7
28. Rinnab L, Simon J, Hautmann RE, Cronauer MV, Hohl K, Buck AK, Reske SN, Mottaghy FM (2009) [(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy. World J Urol 27:619-25. doi: 10.1007/s00345-009-0371-7
29. Picchio M, Briganti A, Fanti S, Heidenreich A, Krause BJ, Messa C, Montorsi F, Reske SN, Thalmann GN (2011) The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol 59:51-60. doi: 10.1016/j.eururo.2010.09.004
30. Breeuwsma AJ, Pruim J, van den Bergh AC, Leliveld AM, Nijman RJ, Dierckx RA, de Jong IJ (2010) Detection of local, regional, and distant recurrence in patients with psa relapse after externalbeam radiotherapy using (11)C-choline positron emission tomography. Int J Radiat Oncol Biol Phys 77:160-4. doi: 10.1016/j.ijrobp.2009.04.090
31. Allen SD, Thompson A, Sohaib SA (2008) The normal post-surgical anatomy of the male pelvis following radical prostatectomy as assessed by magnetic resonance imaging. Eur Radiol 18:1281-91. doi: 10.1007/s00330-008-0867-3
32. Wasserman NF, Kapoor DA, Hildebrandt WC, Zhang G, Born KM, Eppel SM, Reddy PK (1992) Transrectal US in evaluation of patients after radical prostatectomy. Part I. Normal postoperative anatomy. Radiology 185:361-6
33. Sella T, Schwartz LH, Swindle PW, Onyebuchi CN, Scardino PT, Scher HI, Hricak H (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231:379-85
34. Panebianco V, Barchetti F, Sciarra A, Musio D, Forte V, Gentile V, Tombolini V, Catalano C (2013) Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging. Eur Radiol 23:1745-52. doi: 10.1007/s00330-013-2768-3
35. Sella T, Schwartz LH, Hricak H (2006) Retained seminal vesicles after radical prostatectomy: frequency, MRI characteristics, and clinical relevance. AJR Am J Roentgenol 186:539-46
36. Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, Sandler H (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65:965-74
37. Wu LM, Xu JR, Gu HY, Hua J, Zhu J, Chen J, Zhang W, Hu J (2013) Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy. Clin Oncol (R Coll Radiol) 25:252-64. doi: 10.1016/j.clon.2012.11.010
38. Pucar D, Shukla-Dave A, Hricak H, Moskowitz CS, Kuroiwa K, Olgac S, Ebora LE, Scardino PT, Koutcher JA, Zakian KL (2005) Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 236:545-53
39. Coakley FV, Teh HS, Qayyum A, Swanson MG, Lu Y, Roach M 3rd, Pickett B, Shinohara K, Vigneron DB, Kurhanewicz J (2004) Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 233:441-8
40. Kim CK, Park BK, Park W, Kim SS (2010) Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience. Abdom Imaging 35:246-52. doi: 10.1007/s00261-008-9495-2

41. Vargas HA, Wassberg C, Akin O, Hricak H (2012) MR imaging of treated prostate cancer. Radiology 262:26-42. doi: 10.1148/radiol.11101996
42. Rouvière O, Valette O, Grivolat S, Colin-Pangaud C, Bouvier R, Chapelon JY, Gelet A, Lyonnet D (2004) Recurrent prostate cancer after external beam radiotherapy: value of contrastenhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings. Urology 63:922-7
43. Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M (2008) Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 70:425-30
44. Hara T, Inoue Y, Satoh T, Ishiyama H, Sakamoto S, Woodhams R, Baba S, Hayakawa K (2012) Diffusion-weighted imaging of local recurrent prostate cancer after radiation therapy: comparison with 22-core three-dimensional prostate mapping biopsy. Magn Reson Imaging 30:1091-8. doi: 10.1016/j.mri.2012.04.022
45. Kim CK, Park BK, Lee HM (2009) Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging 29:391-7. doi: 10.1002/jmri.21645
46. Breeuwsma AJ, Pruim J, van den Bergh AC, Leliveld AM, Nijman RJ, Dierckx RA, de Jong IJ (2010) Detection of local, regional, and distant recurrence in patients with psa relapse after externalbeam radiotherapy using (11)C-choline positron emission tomography. Int J Radiat Oncol Biol Phys 77:160-4. doi: 10.1016/j.ijrobp.2009.04.090
47. Ceci F, Castellucci P, Graziani T, Schiavina R, Brunocilla E, Mazzarotto R, Ntreta M, Lodi F, Martorana G, Fanti S (2014) 11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT. Eur J Nucl Med Mol Imaging 41:878-86. doi: 10.1007/s00259-013-2655-9
48. Beer AJ, Eiber M, Souvatzoglou M, Holzapfel K, Ganter C, Weirich G, Maurer T, Kübler H, Wester HJ, Gaa J, Krause BJ (2011) Restricted water diffusibility as measured by diffusionweighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. Mol Imaging Biol 13:352-61. doi: 10.1007/s11307-010-0337-6
49. Hövels AM, Heesakkers RA, Adang EM, Jager GJ, Strum S, Hoogeveen YL, Severens JL, Barentsz JO (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63:387-95. doi: 10.1016/j.crad.2007.05.022
50. Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Hammer J, Loidl W, Pirich C, Fogelman I, Langsteger W (2009) The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT. Mol Imaging Biol 11:446-54. doi: 10.1007/s11307-009-0217-0

51. Logan JK, Rais-Bahrami S, Turkbey B, Gomella A, Amalou H, Choyke PL, Wood BJ, Pinto PA (2013) Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int. doi: 10.1111/bju.12593. [Epub ahead of print]
52. Marks L, Young S, Natarajan S (2013) MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol 23:43-50. doi: 10.1097/MOU.0b013e32835ad3ee
53. Mauri G, Cova L, De Beni S, Ierace T, Tondolo T, Cerri A, Goldberg SN, Solbiati L (2014) Real-Time US-CT/MRI Image Fusion for Guidance of Thermal Ablation of Liver Tumors Undetectable with US: Results in 295 Cases. Cardiovasc Intervent Radiol. [Epub ahead of print]
54. Delongchamps NB, Peyromaure M, Schull A, Beuvon F, Bouazza N, Flam T, Zerbib M, Muradyan N, Legman P, Cornud F (2013) Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol 189:493-9. doi: 10.1016/j.juro.2012.08.195
55. Puech P, Rouvière O, Renard-Penna R, Villers A, Devos P, Colombel M, Bitker MO, Leroy X, Mège-Lechevallier F, Comperat E, Ouzzane A, Lemaitre L (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. Radiology 268:461-9. doi: 10.1148/radiol.13121501

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more